Transfusion medicine

Recent Updates

Published: 
Jan 17, 2019
Chapter 1

This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients. 

Transfusion
Modified on: 
Feb 26, 2019

Transfusion-related acute lung injury (TRALI) is a rare but serious syndrome characterized by sudden acute respiratory distress following transfusion. It is defined as new, acute lung injury (ALI) during or within six hours after blood product administration in the absence of temporally-associated risk factors for ALI. All plasma-containing blood products have been implicated in TRALI, including rare reports with IVIg and cryoprecipitate.

Transfusion
Published: 
Aug 10, 2018
Chapter 4

Immune globulin (Ig) products are generated from plasma collected from a large number of carefully screened donors. Ig products may be used as replacement therapy for immunodeficiency patients or as immunomodulatory therapy for autoimmune and alloimmune disorders. Ig products include intravenous Ig (IVIg), subcutaneous Ig (SCIg), RhD Ig (RhIg) and hyperimmune globulins.

Transfusion

Upcoming Events

When
March 28, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Presented by:

Dawn Maze, MD, FRCPC, MSc
Division of Medical Oncology and Hematology, PMH
Assistant Professor, University of Toronto

Learning Objectives:

1. To review the evidence for prophylactic platelet transfusions in patients with hematologic malignancies.
2. To discuss the potential role of tranexamic acid to reduce bleeding and the need for platelet transfusions.
3. To present an ongoing Canadian pilot study of tranexamic acid vs. platelet transfusions in patients undergoing autologous transplantation.

 

Transfusion
When
April 9, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Transfusion

Blog

Modified on: 
Mar 7, 2019

This primer is part I of our new series exploring the future of blood banking. Given that D is also for Development: Canadian Blood Services and the Centre for Innovation have been following the development of pathogen inactivation technologies and how they can be used to improve safety. Read-on to learn more about these technologies and their potential to shift the blood safety paradigm.

Modified on: 
Feb 27, 2019

This month’s Research Unit describes efforts by researchers to create a simulation and modelling study to understand how the risk of transfusion-transmission of HTLV would change if the screening were modified.

Modified on: 
Feb 21, 2019

Welcome to our new R.E.D. blog series where we focus on our Centre for Innovation development projects to give you a glimpse into the future of blood banking... our future!